Ustekinumab in the treatment of patients with hidradenitis suppurativa: multicenter case series and systematic review.
Conclusion: These findings suggest that ustekinumab may be an effective and safe option for patients with HS who fail to respond to first-line therapies.
PMID: 32279593 [PubMed - as supplied by publisher]
Source: Journal of Dermatological Treatment - Category: Dermatology Tags: J Dermatolog Treat Source Type: research
More News: Chronic Pain | Dermatology | Epidemiology | Hidradenitis | Humira | Pain | Skin | Stelara | Study